Arvinas, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Arvinas, Inc. now
Current reporting with the operating signal separated from the noise.
Arvinas, Inc. (ARVN) Q4 2025 Earnings Call Transcript
Investors are testing whether Arvinas, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Arvinas, Inc. (ARVN) Q3 2025 Earnings Call Transcript
Investors are testing whether Arvinas, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Arvinas, Inc. Reports Positive Phase 3 Trial Results and Announces Workforce Reduction to Extend Cash Runway
The story matters when it changes Arvinas, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Arvinas, Inc. to Present Preclinical Data for ARV-393 at AACR Annual Meeting 2025
The story matters when it changes Arvinas, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ARVN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Arvinas, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →